Glenmark Pharmaceuticals has entered (PDF) the subcutaneous checkpoint inhibitor space, agreeing to pay "low double-digit millions" for the chance to launch envafolimab in markets including India ...

Glenmark shares on Monday ended 0.68% up at ₹1,600.85 apiece on BSE. New Delhi: Glenmark Pharmaceuticals on Monday said it will launch cancer treatment drug zanubrutinib in India following ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% ...

Under this agreement, Glenmark will register and commercialize BeiGene’s oncology medicines, tislelizumab and zanubrutinib in India. Speaking on this partnership, Alok Malik, president and business ...

A federal judge has approved a $70 million settlement reached by a class of drug purchasers with Merck & Co Inc and Glenmark Pharmaceuticals over claims that the two drugmakers colluded to delay ...